Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oxford Biomedica PLC Remuneration Information 2024

Jan 2, 2024

5190_def-14a_2024-01-02_9230a78e-7d72-4674-b639-781a9afdf83a.html

Remuneration Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 2617Y

Oxford Biomedica PLC

02 January 2024

Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Employee Share Option Scheme
Period of return: From: 1 July 2023 To: 31 December 2023
Balance of unallotted securities under scheme(s) from previous return: 309,426
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 2,905
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 306,521
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Long Term Incentive Plan
Period of return: From: 1 July 2023 To: 31 December 2023
Balance of unallotted securities under scheme(s) from previous return: 442,977
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 192,609
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 250,368
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Deferred Bonus Plan
Period of return: From: 1 July 2023 To: 31 December 2023
Balance of unallotted securities under scheme(s) from previous return: 296,272
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 28,200
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 268,072
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: Sharesave Scheme
Period of return: From: 1 July 2023 To: 31 December 2023
Balance of unallotted securities under scheme(s) from previous return: 339,753
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): NIL
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 339,753
Name of contact: Natalie Walter, Company Secretary
Telephone number of contact: 01865 783000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRTLBFTMTITBBJ